Kyto Technology & Life Science, Inc. engages in developing a specialized vehicle for early stage technology and life science companies. It provides professional advisory and investment services. The company was founded by Jean-Luc Berger on March 5, 1999 and is headquartered in Los Altos Hills, CA.
Company profile
Ticker
KBPH
Exchange
Website
CEO
Paul M. Russo
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
B TWELVE INC, KYTO BIOPHARMA INC
SEC CIK
Corporate docs
IRS number
651086538
KBPH stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
11 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 22
SC TO-I/A
Issuer tender offer statement (amended)
6 May 22
8-K
Other Events
6 May 22
SC TO-I/A
Issuer tender offer statement (amended)
5 May 22
SC TO-I/A
Issuer tender offer statement (amended)
4 May 22
SC TO-I/A
Issuer tender offer statement (amended)
22 Apr 22
CORRESP
Correspondence with SEC
22 Apr 22
UPLOAD
Letter from SEC
18 Apr 22
UPLOAD
Letter from SEC
12 Apr 22
Latest ownership filings
4
GEORGES BENARROCH
14 Apr 21
4
GEORGES BENARROCH
18 Mar 21
4
GEORGES BENARROCH
3 Dec 20
4
Change in insider ownership
3 Dec 20
4
Change in insider ownership
18 Sep 19
4
GEORGES BENARROCH
7 Jun 18
SC 13D
Kyto Biopharma Inc
22 Feb 18
4
GEORGES BENARROCH
21 Feb 18
SC 13G/A
Kyto Biopharma Inc
13 Feb 15
SC 13D
Kyto Biopharma Inc
9 Oct 14
Financial summary
Quarter (USD) | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 608.22 k | 608.22 k | 608.22 k | 608.22 k | 608.22 k | |
Cash burn (monthly) | (no burn) | 247.81 k | 224.95 k | 482.97 k | 342.88 k | |
Cash used (since last report) | n/a | 6.90 mm | 6.26 mm | 13.45 mm | 9.55 mm | |
Cash remaining | n/a | -6.29 mm | -5.66 mm | -12.84 mm | -8.94 mm | |
Runway (months of cash) | n/a | -25.4 | -25.1 | -26.6 | -26.1 |